Alternative RUNX1 Promoter Regulation by Wnt/β-Catenin Signaling in Leukemia Cells and Human Hematopoietic...

Area of Science:

• Molecular Biology
• Hematopoiesis
• Cancer Biology

Background:

• RUNX genes are crucial for development, regulated by distinct promoters (P1, P2).
• Previous work showed beta-catenin increases Runx1 mRNA and ETO proximity in hematopoietic progenitors.
• Wnt/beta-catenin signaling plays a role in cell differentiation and cancer.

Purpose of the Study:

• To investigate the specific effects of Wnt/beta-catenin signaling on Runx1 mRNA isoforms.
• To identify the regulatory elements responsible for differential Runx1 promoter activation.
• To understand the role of P1-Runx1 in hematopoiesis and leukemia.

Main Methods:

• Induction of Wnt/beta-catenin signaling in leukemia cell lines (HL60, Jurkat) and CD34(+) progenitors.
• Analysis of Runx1 mRNA isoform production (P1 vs. P2).
• Gain- and loss-of-function experiments to assess the role of a specific regulatory region and TCF/LEF-binding element.

Main Results:

• Wnt/beta-catenin signaling selectively induced the longer distal P1-Runx1 mRNA isoform.
• A conserved TCF/LEF-binding element (-20/-16 bp) upstream of the P1 transcription start site mediates this induction.
• Differential P1-Runx1 expression was confirmed through functional experiments.

Conclusions:

• The distal P1-Runx1 promoter is a direct transcriptional target of Wnt/beta-catenin signaling.
• This pathway may be critical for normal hematopoiesis.
• Dysregulation of P1-Runx1 could contribute to the transition of hematopoietic stem cells into malignant cells during leukemia onset or progression.